The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...

The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...

Hone Health reports that, when it comes to slowing aging and extending lifespan, few interventions are as well-supported by science as fat loss.

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

The decision will not impact Medicare's existing coverage for drugs like Ozempic and Mounjaro, which can be used for weight ...

Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...